| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |